The SELECT study: A multicenter phase II trial of adjuvant erlotinib in resected epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC) Meeting Abstract
| Authors: | Neal, J. W.; Pennell, N. A.; Govindan, R.; Lanuti, M.; Rosovsky, R. P. G.; Heist, R. S.; Shaw, A. T.; Temel, J. S.; Muzikansky, A.; Janne, P. A.; Lynch, T. J.; Azzoli, C. G.; Sequist, L. V. |
| Abstract Title: | The SELECT study: A multicenter phase II trial of adjuvant erlotinib in resected epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC) |
| Meeting Title: | 48th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 30 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2012 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2012-05-20 |
| Language: | English |
| ACCESSION: | WOS:000318009801374 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2012.30.15_suppl.7010 |
| Notes: | Meeting Abstract: 7010 -- Source: Wos |
